A Patient's Guide to Deep Vein Thrombosis (DVT)

Published by Dr. Kasturi Mandal | Last updated: July 2025

Deep Vein Thrombosis (DVT) is a medical condition that occurs when a blood clot (thrombus) forms in a deep vein, usually in the legs. It can cause pain and swelling and may lead to serious complications if the clot travels to the lungs, causing a pulmonary embolism (PE).

Diagram showing a blood clot (thrombus) forming in a deep vein of the lower leg. — A DVT is a blood clot that forms in a deep vein, obstructing blood flow.

Causes and Risk Factors

Key risk factors for developing a DVT include:

Prolonged immobility (e.g., long flights, bed rest)
Major surgery or injury (especially to the hips or legs)
Medical conditions like cancer or inherited clotting disorders
Hormonal factors (e.g., birth control pills, pregnancy)
Increased age, obesity, and smoking

Symptoms & Complications

While some cases are asymptomatic, common signs of a DVT in the leg include swelling, pain or tenderness, red or discolored skin, and a feeling of warmth. The most serious complication is a **Pulmonary Embolism (PE)**, a life-threatening condition where the clot breaks off and travels to the lungs, causing sudden shortness of breath and chest pain.

Diagnosis and Treatment

The most common diagnostic tool is a non-invasive **ultrasound** of the leg. Treatment primarily involves **anticoagulants (blood thinners)**, such as heparin, warfarin, or newer Direct Oral Anticoagulants (DOACs) like apixaban and rivaroxaban. Compression stockings are also often recommended to help with swelling.

A doctor performing a leg ultrasound on a patient to check for deep vein thrombosis. — Ultrasound is the primary non-invasive method for diagnosing a DVT.

Evidence-Based Management of DVT

The treatment of DVT is guided by extensive clinical research. Here is a summary of current evidence and recommendations from major medical societies.

1. Direct Oral Anticoagulants (DOACs) vs. Warfarin

Systematic reviews show that DOACs are as effective as traditional warfarin for treating DVT, but with a significantly lower risk of major bleeding complications.

2. Prevention After Surgery

For patients undergoing hip or knee replacement, network meta-analyses have shown that DOACs like apixaban and rivaroxaban are more effective than older medications in preventing post-operative DVT.

3. Compression Stockings

While effective at reducing DVT risk in high-risk scenarios like long-haul travel, recent evidence suggests compression stockings may not be effective in preventing long-term complications like post-thrombotic syndrome (PTS) for all patients, though they can help manage symptoms.

4. Duration of Therapy

The standard duration for anticoagulation is typically 3 to 6 months. However, for patients with unprovoked or recurrent clots, indefinite or long-term therapy may be recommended based on an individual risk assessment.